Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atara Biotherap (NQ: ATRA )

12.75 USD -0.30 (-2.30%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 592,016
Open 12.90
Bid (Size) 12.50 (1)
Ask (Size) 13.00 (3)
Prev. Close 13.05
Today's Range 12.69 - 13.05
52wk Range 11.33 - 28.20
Shares Outstanding 84,076,737
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and... 
From Business Wire News Releases
Atara Biotherapeutics Joins the Rare Disease Company Coalition Alongside Industry Gamechangers
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and... 
From Business Wire News Releases

Performance

YTD
-35.08%
-35.08%
1 Month
-18.01%
-18.01%
3 Month
-9.32%
-9.32%
6 Month
-30.93%
-30.93%
1 Year
-2.15%
-2.15%

More News

Read More
Atara Biotherapeutics Presents Positive Tab-cel® Long-Term Overall Survival Data for Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease After Solid Organ Transplant at ATC 2021 Virt
From Business Wire News Releases
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Business Wire News Releases
First Week of March 2022 Options Trading For Atara Biotherapeutics
Tags Stocks
From Market News Video
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Business Wire News Releases
Bag This Bargain Even Cheaper Than Chief Commercial Officer Yarema Did
Tags Stocks
From Market News Video
Atara Biotherapeutics to Participate at the Cowen Virtual Oncology Innovation Summit
From Business Wire News Releases
Analysts Forecast 21% Upside For IBBQ
Tags ETFs
From ETF Channel
Atara Biotherapeutics Names Cell Therapy & Oncology Leader Cokey Nguyen, Ph.D. as Chief Scientific Officer
From Business Wire News Releases
Wednesday 6/16 Insider Buying Report: CORT, ATRA
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.